Literature DB >> 11966944

Wild-type and 'a' epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigen and antibody.

Steven J Mesenas1, Wan C Chow, Yi Zhao, Gek K Lim, Chong J Oon, Han S Ng.   

Abstract

AIMS: This study aims to examine the genomic variants of the 'a' epitope in chronic hepatitis B virus (HBV) carriers positive for both hepatitis B surface antigen (HBsAg) and antibody to HBsAg (anti-HBs).
METHODS: Eighteen HBV carriers were studied. Hepatitis B virus (HBV) DNA was extracted and the 'a' epitope region was amplified and sequenced.
RESULTS: Eighteen Chinese asymptomatic HBV carriers were studied. There were 13 patients who were positive for both HBsAg and anti-HBs. Of these, one patient had only wild-type HBV, three had a viral mixture, and five had only 'a' epitope variant HBV. Of the three patients with a viral mixture, all had variants in the less conserved region (123-137). Of the five patients with pure HBsAg mutants, three had variants in the less conserved region while two had variants in the highly conserved region. In this study with a limited number of patients, the serum alanine aminotransferase (ALT) levels were higher in patients with wild-type HBV, compared with those with either 'a' epitope variants or a viral mixture consisting of wild type and variants.
CONCLUSION: Eight of the nine (89%) patients positive for both HBsAg and anti-HBs harbored an 'a' epitope variant. The lower ALT levels seen in patients who had either pure 'a' epitope variant or a mixture of wild type and mutants suggest that a closer monitoring of these 'a' epitope variants should be required, as patients carrying these infectious viral strains may remain asymptomatic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11966944     DOI: 10.1046/j.1440-1746.2002.02627.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited.

Authors:  Jennifer Leong; Derek Lin; Mindie H Nguyen
Journal:  World J Clin Cases       Date:  2016-03-16       Impact factor: 1.337

2.  Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants.

Authors:  Olivier Lada; Yves Benhamou; Thierry Poynard; Vincent Thibault
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

3.  Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China.

Authors:  Yang Yong-Lin; Fu Qiang; Zhang Ming-Shun; Cai Jie; Ma Gui-Ming; Huang Zu-Hu; Cai Xu-Bing
Journal:  Virol J       Date:  2012-04-14       Impact factor: 4.099

4.  HBsAg/HBsAb double positive hepatitis B virus infection model in vitro and in vivo.

Authors:  Zhenhua Zhang; Lei Li; Yongjun Tian; Jianbo Xia; Youhua Hao; Xu Li; Mengji Lu; Dongliang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

5.  Infection with hepatitis B virus carrying novel pre-S/S gene mutations in female siblings vaccinated at birth: two case reports.

Authors:  Ming-Wei Lai; Christopher S-H Yeh; Chau-Ting Yeh
Journal:  J Med Case Rep       Date:  2010-06-23

6.  Vaccination Coverage and Awareness of Hepatitis B Virus Among Healthcare Students at a University in Cyprus.

Authors:  Zoe Roupa; Maria Noula; Evi Farazi; Antonis Stylianides; Christos Papaneophytou
Journal:  Mater Sociomed       Date:  2019-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.